Friday, November 15, 2024
HomeIndustriesHealthcare

Healthcare

Emergence Therapeutics raises €87 million Series A financing to advance Nectin-4 ADC

Emergence Therapeutics AG, a biopharmaceutical company developing novel antibody drug conjugates (ADC) for the treatment of cancers with high unmet needs, today announces that...

Vaccitech reports promising interim efficacy analysis in Phase 1b/2a clinical study in chronic HBV

Vaccitech plc, a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapeutic and vaccines, announced a promising interim analysis of safety...

Clover Signs COVID-19 Vaccine Supply Agreement with UNICEF

Clover Biopharmaceuticals, Ltd. a global clinical-stage biotechnology company developing novel vaccines and biologic therapeutic candidates, today announced that they have entered into a long-term...

Aligos Presents Update of Chronic Hepatitis B Pipeline Portfolio at HEP DART 2021

Aligos Therapeutics, Inc. a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in viral and liver diseases, announced...

EyePoint Pharmaceuticals and Harrow Health’s ImprimisRx Announce Expanded U.S. Commercial Alliance for DEXYCU®

EyePoint Pharmaceuticals, Inc. a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders, and...
0FansLike
0FollowersFollow
spot_img

Hot Topics